Silsirivanit A, Alvarez M, Grijaldo-Alvarez S, Gogte R, Kitkhuandee A, Piyawattanametha N
J Proteome Res. 2025; 24(3):1402-1413.
PMID: 39905713
PMC: 11894639.
DOI: 10.1021/acs.jproteome.4c01090.
Duca M, Malagolini N, Pucci M, Cogez V, Harduin-Lepers A, DallOlio F
Sci Rep. 2025; 15(1):1821.
PMID: 39805916
PMC: 11729888.
DOI: 10.1038/s41598-025-85450-z.
Vitale F, Zileri Dal Verme L, Paratore M, Negri M, Nista E, Ainora M
Biomedicines. 2025; 12(12.
PMID: 39767746
PMC: 11673965.
DOI: 10.3390/biomedicines12122840.
Liu R, Yang T, Huang J, Xiao Z, Liu J, Li Z
BMC Cancer. 2024; 24(1):947.
PMID: 39095785
PMC: 11297740.
DOI: 10.1186/s12885-024-12712-w.
Li Y, Chen Y, Wang D, Wu L, Li T, An N
Front Immunol. 2024; 15:1442722.
PMID: 39081317
PMC: 11286416.
DOI: 10.3389/fimmu.2024.1442722.
Identification of ALG3 as a potential prognostic biomarker in lung adenocarcinoma.
Yuan Y, Xie B, Guo D, Liu C, Jiang G, Lai G
Heliyon. 2023; 9(7):e18065.
PMID: 37539167
PMC: 10395363.
DOI: 10.1016/j.heliyon.2023.e18065.
Glycomic, Glycoproteomic, and Proteomic Profiling of Philippine Lung Cancer and Peritumoral Tissues: Case Series Study of Patients Stages I-III.
Alvarez M, Zhou Q, Tena J, Barboza M, Wong M, Xie Y
Cancers (Basel). 2023; 15(5).
PMID: 36900350
PMC: 10001221.
DOI: 10.3390/cancers15051559.
The Mutual Relationship between Glycosylation and Non-Coding RNAs in Cancer and Other Physio-Pathological Conditions.
Duca M, Malagolini N, DallOlio F
Int J Mol Sci. 2022; 23(24).
PMID: 36555445
PMC: 9781064.
DOI: 10.3390/ijms232415804.
-Glycan and Glycopeptide Serum Biomarkers in Philippine Lung Cancer Patients Identified Using Liquid Chromatography-Tandem Mass Spectrometry.
Alvarez M, Zhou Q, Tena J, Lebrilla C, Completo G, Heralde 3rd F
ACS Omega. 2022; 7(44):40230-40240.
PMID: 36385894
PMC: 9647785.
DOI: 10.1021/acsomega.2c05111.
An Integrated Mass Spectrometry-Based Glycomics-Driven Glycoproteomics Analytical Platform to Functionally Characterize Glycosylation Inhibitors.
Alvarez M, Zhou Q, Grijaldo S, Lebrilla C, Nacario R, Heralde 3rd F
Molecules. 2022; 27(12.
PMID: 35744954
PMC: 9228227.
DOI: 10.3390/molecules27123834.
Glycosyltransferases in Cancer: Prognostic Biomarkers of Survival in Patient Cohorts and Impact on Malignancy in Experimental Models.
Pucci M, Duca M, Malagolini N, DallOlio F
Cancers (Basel). 2022; 14(9).
PMID: 35565254
PMC: 9100214.
DOI: 10.3390/cancers14092128.
The Cancer-Associated Antigens Sialyl Lewis and Sd: Two Opposite Faces of Terminal Glycosylation.
DallOlio F, Pucci M, Malagolini N
Cancers (Basel). 2021; 13(21).
PMID: 34771437
PMC: 8582462.
DOI: 10.3390/cancers13215273.
B4GALNT2 Controls Sd and SLe Antigen Biosynthesis in Healthy and Cancer Human Colon.
Groux-Degroote S, Vicogne D, Cogez V, Schulz C, Harduin-Lepers A
Chembiochem. 2021; 22(24):3381-3390.
PMID: 34397142
PMC: 9290495.
DOI: 10.1002/cbic.202100363.
ALG3 contributes to stemness and radioresistance through regulating glycosylation of TGF-β receptor II in breast cancer.
Sun X, He Z, Guo L, Wang C, Lin C, Ye L
J Exp Clin Cancer Res. 2021; 40(1):149.
PMID: 33931075
PMC: 8086123.
DOI: 10.1186/s13046-021-01932-8.
Glycosyltransferase B4GALNT2 as a Predictor of Good Prognosis in Colon Cancer: Lessons from Databases.
Pucci M, Malagolini N, DallOlio F
Int J Mol Sci. 2021; 22(9).
PMID: 33919332
PMC: 8122605.
DOI: 10.3390/ijms22094331.
Biophysical characterization of melanoma cell phenotype markers during metastatic progression.
Sobiepanek A, Paone A, Cutruzzola F, Kobiela T
Eur Biophys J. 2021; 50(3-4):523-542.
PMID: 33730175
PMC: 8190004.
DOI: 10.1007/s00249-021-01514-8.
Glycosyltransferase ST6Gal-I promotes the epithelial to mesenchymal transition in pancreatic cancer cells.
Britain C, Bhalerao N, Silva A, Chakraborty A, Buchsbaum D, Crowley M
J Biol Chem. 2020; 296:100034.
PMID: 33148698
PMC: 7949065.
DOI: 10.1074/jbc.RA120.014126.
The Sd Synthase B4GALNT2 Reduces Malignancy and Stemness in Colon Cancer Cell Lines Independently of Sialyl Lewis X Inhibition.
Pucci M, Gomes Ferreira I, Malagolini N, Ferracin M, DallOlio F
Int J Mol Sci. 2020; 21(18).
PMID: 32911675
PMC: 7555213.
DOI: 10.3390/ijms21186558.
Esophageal, gastric and colorectal cancers: Looking beyond classical serological biomarkers towards glycoproteomics-assisted precision oncology.
Fernandes E, Sores J, Cotton S, Peixoto A, Ferreira D, Freitas R
Theranostics. 2020; 10(11):4903-4928.
PMID: 32308758
PMC: 7163443.
DOI: 10.7150/thno.42480.
High Expression of the Sd Synthase B4GALNT2 Associates with Good Prognosis and Attenuates Stemness in Colon Cancer.
Pucci M, Gomes Ferreira I, Orlandani M, Malagolini N, Ferracin M, DallOlio F
Cells. 2020; 9(4).
PMID: 32290493
PMC: 7226961.
DOI: 10.3390/cells9040948.